6505--Nuclear Medicine Radiopharmaceuticals (VA-26-00043023)

ent and incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC FY26.03A 12/26/2025, FAC 2025-06 10/01/2025. This solicitation is Unrestricted. The associated North American Industrial Classification System (NAICS) code for this procurement is 325412, with a small business size standard of 1300 employees. The FSC/PSC is 6505. The Department of Veterans Affairs Western New York Healthcare System located at 3495 Bailey Avenue, Buffalo, NY 14215 has a requirement for a United States Nuclear Regulatory Commission (US NRC) and Food and Drug Administration (FDA) Licensed Contractor to provide radiopharmaceuticals for the Nuclear Medicine Department for patient care. The VA Western NY Healthcare System at Buffalo intends shall award a Base year contract with three Option year firm fixed price contract to a licensed Radiopharmacy authorized to manufacture and distribute Radiopharmaceutical Supplies in New York State with a period of performance of July 1, 2026 through June 30, 2030. The Contractor agrees in accordance with the terms and conditions listed in this statement of work (SOW) to furnish Radiopharmaceuticals in accordance with Local, State, and Federal Regulations. The Contractor shall be able to provide all items listed in the Schedule of Required Supplies with deliveries as needed. Multiple awards shall not be made and subcontracting is not authorized. Under the Atomic Energy Act, the United States Nuclear Regulatory Commission (NRC) is responsible for regulating uses of radioactive material including radio pharmaceuticals. The NRC requires all nuclear medicine facilities to be licensed. The license assures that the facility has a radiation protection program to protect both the patients and the staff. In addition, the staff must meet certain standards of training and experience before they are allowed to administer radioactive material to patients. Each state has one or more radiation programs that ensure safe use of radioactive materials. The NRC has transferred regulatory authority over the use of this material to 34 NRC Agreement States. In these states, the regulatory authority inspects the facility to ensure the staff is trained properly and the equipment is operating safely. The FDA s Center for Drug Evaluation and Research regulates the radio pharmaceuticals, ensuring effectiveness and patient safety. The mission of the National Institute of Standards and Technology (NIST) is to develop and promote measurement, standards, and technology to enhance productivity, facilitate trade, and improve the quality of life. Although a non-regulatory federal agency, NIST develops the standards for correct patient dosage of radiopharmaceuticals. All interested companies shall provide quotations for the following: Supplies/Services Please Note: Offerors must provide pricing on all items in the Schedule of Required Supplies. Prices quoted are all inclusive including all associated costs including shipping, handling, packaging, storage, licenses etc. excluding emergency delivery, Pharmacist After-Hour Emergency Call-Back, and Weekend White Blood Cell labeling charge. Year 1: July 1, 2026 through June 30, 2027 CLIN Radiopharmaceutical Unit of Measure Qty per year Size Price For Each mCi or Bulk Total Price Number of Minutes Needed to Prepare Product at Radiopharmacy NDC Of Offered Product 0001 Tc99m Sestamibi Unit dose 1,500 8mCi 0002 Tc99m Sestamibi Unit dose 10 20mCi 0003 Tc99m Sestamibi Unit dose 15 25mCi 0004 Tc99m Sestamibi Unit dose 1,500 28mCi 0005 Tc99m Sestamibi Unit dose 450 30mCi 0006 Tc99m Ceretec (brain imaging) Unit dose 2 20mCi 0007 I-123 Ioflupane Unit dose 1 5mCi 0008 Tc99m HMPAO WBC Unit dose 3 20mCi 0009 Tc99m DTPA Unit dose 80 30mCi 0010 Tc99m DMSA Unit dose 1 5mCi 0011 Tc99m Hepatolite Unit dose 70 6mCi 0012 Tc99m Mebrofenin Unit dose 12 6mCi 0013 Tc99m MAA Unit dose 20 4mCi 0014 Tc99m MAA Unit dose 80 6mCi 0015 Tc99m MAG3 Unit dose 100 7mCi 0016 Tc99m MDP Unit dose 300 23mCi 0017 Tc99m Neurolite Unit dose 2 25mCi 0018 Tc99m Sulfur Colloid Unit dose 45 7mCi 0019 Tc99m Sulfur colloid filtered Unit dose 10 1.5mCi 0020 Tc99m Choletec Unit dose 5 7mCi 0021 Tc99m (Pertechnetate) Unit dose 15 5mCi 0022 Tc99m (Pertechnetate) Unit dose 5 10mCi 0023 Tc99m (Pertechnetate Unit dose 35 28mCi 0024 Tc99m (Pertechnetate Unit dose 10 30mCi 0025 Tc99m (Pertechnetate Bulk 4 250mCi bulk 0026 Tc99m PYP Unit dose 12 20mCi 0027 Tl-201 Unit dose 7 1mCi 0028 Tl-201 Unit dose 7 3mCi 0029 Tl-201 Unit dose 3 4mCi 0030 I-123MIBG Unit dose 1 10mCi 0031 I-123 NaI caps (200uci) Capsule 100 200uCi 0032 I-131 NaI caps (therapeutic) Capsule 2 60mCi 0033 I-131 NaI caps (therapeutic) Capsule 2 100mCi 0034 I-131 NaI caps (therapeutic) Capsule 3 125mCi 0035 I-131 NaI caps (therapeutic) Capsule 1 150mCi 0036 I-131 NaI caps (therapeutic) Capsule 1 175mCi 0037 I-131 NaI caps (therapeutic) Capsule 1 200mCi 0038 I-131 NaI caps (diagnostic) Capsule 3 2mCi 0039 I-131 NaI caps (diagnostic) Capsule 4 3mCi 0040 I-131 NaI caps (diagnostic) Capsule 7 4mCi 0041 I-131 NaI caps (diagnostic) Capsule 4 5mCi 0042 I-131 NaI caps (diagnostic) Capsule 1 7mCi 0043 In111 WBC Unit dose 5 450uCi 0044 In111 Octreoscan Unit dose 2 6mCi 0045 In111 DTPA Unit dose 1 0.5mCi 0046 Ga-67 Unit dose 1 6mCi 0047 Ga-68 DOTATATE Unit dose 12 4-5.4mCi 0048 Ga-68 PSMA Unit dose 1 3-7mCi 0049 Aerovent Jr (lung aerosol tubing) Kit 100 Kit 0050 Kinevac CCK Unit dose 30 reconstituted per patient weight 1.4ugm/kg 0051 Ultra-tag kits Kit 5 boxes 5 kits each Kit 0052 Pyrophosphate kits Kit 30 vials Kit 0053 Sterile water vial 20 vials vial 0054 Sealed sources for QC procedures- plus removal/disposal of depleted sources Sealed source 2 per year Varies 0055 Emergency orders over 2 deliveries/day- to include pharmacist preparation and delivery Delivery Approximately 3/week (ESTIMATED 156 DELIVERIES ANNUALLY) Order N/A Year Two: July 1, 2027 through June 30, 2028 CLIN Radiopharmaceutical Unit of Measure Qty per year Size Price For Each mCi or Bulk Total Price Number of Minutes Needed to Prepare Product at Radiopharmacy NDC Of Offered Product 0001 Tc99m Sestamibi Unit dose 1,500 8mCi 0002 Tc99m Sestamibi Unit dose 10 20mCi 0003 Tc99m Sestamibi Unit dose 15 25mCi 0004 Tc99m Sestamibi Unit dose 1,500 28mCi 0005 Tc99m Sestamibi Unit dose 450 30mCi 0006 Tc99m Ceretec (brain imaging) Unit dose 2 20mCi 0007 I-123 Ioflupane Unit dose 1 5mCi 0008 Tc99m HMPAO WBC Unit dose 3 20mCi 0009 Tc99m DTPA Unit dose 80 30mCi 0010 Tc99m DMSA Unit dose 1 5mCi 0011 Tc99m Hepatolite Unit dose 70 6mCi 0012 Tc99m Mebrofenin Unit dose 12 6mCi 0013 Tc99m MAA Unit dose 20 4mCi 0014 Tc99m MAA Unit dose 80 6mCi 0015 Tc99m MAG3 Unit dose 100 7mCi 0016 Tc99m MDP Unit dose 300 23mCi 0017 Tc99m Neurolite Unit dose 2 25mCi 0018 Tc99m Sulfur Colloid Unit dose 45 7mCi 0019 Tc99m Sulfur colloid filtered Unit dose 10 1.5mCi 0020 Tc99m Choletec Unit dose 5 7mCi 0021 Tc99m (Pertechnetate) Unit dose 15 5mCi 0022 Tc99m (Pertechnetate) Unit dose 5 10mCi 0023 Tc99m (Pertechnetate Unit dose 35 28mCi 0024 Tc99m (Pertechnetate Unit dose 10 30mCi 0025 Tc99m (Pertechnetate Bulk 4 250mCi bulk 0026 Tc99m PYP Unit dose 12 20mCi 0027 Tl-201 Unit dose 7 1mCi 0028 Tl-201 Unit dose 7 3mCi 0029 Tl-201 Unit dose 3 4mCi 0030 I-123MIBG Unit dose 1 10mCi 0031 I-123 NaI caps (200uci) Capsule 100 200uCi 0032 I-131 NaI caps (therapeutic) Capsule 2 60mCi 0033 I